Home

Út Lány Zöld ro 20 1724 határozott természetes újjáéledés

RO 20-1724 Supplier | CAS 29925-17-5 | Focus Biomolecules
RO 20-1724 Supplier | CAS 29925-17-5 | Focus Biomolecules

Displacement of [3H]-rolipram by rolipram, Ro 20-1724, and hesperetin... |  Download Scientific Diagram
Displacement of [3H]-rolipram by rolipram, Ro 20-1724, and hesperetin... | Download Scientific Diagram

Regulation of 3′,5′-cAMP in Preglomerular Smooth Muscle and Endothelial  Cells From Genetically Hypertensive Rats | Hypertension
Regulation of 3′,5′-cAMP in Preglomerular Smooth Muscle and Endothelial Cells From Genetically Hypertensive Rats | Hypertension

29925-17-5 | Ro 20-1724 | 4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one;  4-[(3-Butoxy-4-methoxyphenyl)methyl]-2-imidazolidinone;  4-(3-Butoxy-4-methoxy benzyl)-2-imidazolidinone;  4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidone; DL-4-(3-Butoxy-4 ...
29925-17-5 | Ro 20-1724 | 4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one; 4-[(3-Butoxy-4-methoxyphenyl)methyl]-2-imidazolidinone; 4-(3-Butoxy-4-methoxy benzyl)-2-imidazolidinone; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidone; DL-4-(3-Butoxy-4 ...

RO 20-1724 Supplier | CAS 29925-17-5 | Focus Biomolecules
RO 20-1724 Supplier | CAS 29925-17-5 | Focus Biomolecules

Ro 20-1724 (4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone, CAS Number:  29925-17-5) | Cayman Chemical
Ro 20-1724 (4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone, CAS Number: 29925-17-5) | Cayman Chemical

Enzo Life Sciences RO-20-1724, (1g), CAS Number: 29925-17-5, Quantity: |  Fisher Scientific
Enzo Life Sciences RO-20-1724, (1g), CAS Number: 29925-17-5, Quantity: | Fisher Scientific

Ro 20-1724 (4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone, CAS Number:  29925-17-5) | Cayman Chemical
Ro 20-1724 (4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone, CAS Number: 29925-17-5) | Cayman Chemical

Ro 20-1724 | CAS 29925-17-5 | PDE4 inhibitor
Ro 20-1724 | CAS 29925-17-5 | PDE4 inhibitor

Antipsychotic-Like Properties of Phosphodiesterase 4 Inhibitors: Evaluation  of 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with  Auditory Event-Related Potentials and Prepulse Inhibition of Startle |  Journal of Pharmacology and ...
Antipsychotic-Like Properties of Phosphodiesterase 4 Inhibitors: Evaluation of 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with Auditory Event-Related Potentials and Prepulse Inhibition of Startle | Journal of Pharmacology and ...

Phosphodiesterase Inhibition by Ro 20-1724 Reduces Hyper-IgE Synthesis by  Atopic Dermatitis Cells In Vitro
Phosphodiesterase Inhibition by Ro 20-1724 Reduces Hyper-IgE Synthesis by Atopic Dermatitis Cells In Vitro

Ro 20-1724 (CAS 29925-17-5): R&D Systems
Ro 20-1724 (CAS 29925-17-5): R&D Systems

Ro 20-1724 - LKT Labs
Ro 20-1724 - LKT Labs

Ro20-1724 | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
Ro20-1724 | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY

Ro 20-1724 | Cas# 29925-17-5 - GlpBio
Ro 20-1724 | Cas# 29925-17-5 - GlpBio

RO 20-1724, cAMP-specific Phosphodiesterase Inhibitor biochemical
RO 20-1724, cAMP-specific Phosphodiesterase Inhibitor biochemical

RO 20-1724, Phosphodiesterase 4 (PDE4) inhibitor (CAS 29925-17-5) (ab141492)
RO 20-1724, Phosphodiesterase 4 (PDE4) inhibitor (CAS 29925-17-5) (ab141492)

Ro-20-1724 - CAS 29925-17-5 - Calbiochem A cell-permeable, selective  inhibitor of cAMP-specific phosphodiesterase (PDE IV; IC = 2 uM). 29925-17-5
Ro-20-1724 - CAS 29925-17-5 - Calbiochem A cell-permeable, selective inhibitor of cAMP-specific phosphodiesterase (PDE IV; IC = 2 uM). 29925-17-5

MilliporeSigma Calbiochem Ro-20-1724 100mg:Protein Analysis Reagents,  Quantity: | Fisher Scientific
MilliporeSigma Calbiochem Ro-20-1724 100mg:Protein Analysis Reagents, Quantity: | Fisher Scientific

RO 20-1724 ≥99% (by TLC) | VWR
RO 20-1724 ≥99% (by TLC) | VWR

Antipsychotic-Like Properties of Phosphodiesterase 4 Inhibitors: Evaluation  of 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with  Auditory Event-Related Potentials and Prepulse Inhibition of Startle |  Journal of Pharmacology and ...
Antipsychotic-Like Properties of Phosphodiesterase 4 Inhibitors: Evaluation of 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with Auditory Event-Related Potentials and Prepulse Inhibition of Startle | Journal of Pharmacology and ...

Ro 20-1724 | ≥99%(HPLC) | Selleck | PDE 阻害剤
Ro 20-1724 | ≥99%(HPLC) | Selleck | PDE 阻害剤

Concentration responses of RO 20-1724 determined in the PDE4 cell line... |  Download Scientific Diagram
Concentration responses of RO 20-1724 determined in the PDE4 cell line... | Download Scientific Diagram

Phosphodiesterase 4 Inhibition Impairs Cocaine-Induced Inhibitory Synaptic  Plasticity and Conditioned Place Preference | Neuropsychopharmacology
Phosphodiesterase 4 Inhibition Impairs Cocaine-Induced Inhibitory Synaptic Plasticity and Conditioned Place Preference | Neuropsychopharmacology

Phosphodiesterase 4 Inhibition Impairs Cocaine-Induced Inhibitory Synaptic  Plasticity and Conditioned Place Preference | Neuropsychopharmacology
Phosphodiesterase 4 Inhibition Impairs Cocaine-Induced Inhibitory Synaptic Plasticity and Conditioned Place Preference | Neuropsychopharmacology

Synergistic Inhibition of Vascular Smooth Muscle Cell Migration by  Phosphodiesterase 3 and Phosphodiesterase 4 Inhibitors | Circulation  Research
Synergistic Inhibition of Vascular Smooth Muscle Cell Migration by Phosphodiesterase 3 and Phosphodiesterase 4 Inhibitors | Circulation Research